Search Browse Earnings

Passage BIO, Inc. — SlamSEC

Passage BIO, Inc.

Nasdaq:PASG

Biological Products, (No Diagnostic Substances)·PHILADELPHIA, PA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$67.3M

FY 2025

Net Income

-$64.8M

FY 2025

EPS (Diluted)

-$21.04

FY 2025

Stock Price

$9.00

+7.1%

2026-03-09

52W Range

$5.12 – $20.00

P/E Ratio

-0.4x

Market Cap

$28.9M

Cash

$37.6M

FY 2025

Total Debt

—

Net Cash

$37.6M

Enterprise Value

-$8.7M

Debt / EBITDA

0.6x

FY 2025

EV / EBITDA

0.1x

Employees

27

FY 2025